Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RVL Pharmaceuticals plc - Ordinary Shares (NQ: RVLP )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about RVL Pharmaceuticals plc - Ordinary Shares

BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Reaches Agreement Regarding Reorganization of Three US Subsidiaries
Via Investor Brand Network
Topics Bankruptcy
Exposures Financial Legal Product Safety
RVL Pharmaceuticals plc (NASDAQ: RVLP) Presents Achievements, Goals at H.C. Wainwright 25th Annual Global Investment Conference in New York City
Via Investor Brand Network
RVL Pharmaceuticals plc (NASDAQ: RVLP) Looking to Capitalize on UPNEEQ’s Significant Potential
Via Investor Brand Network
BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)
Via Investor Brand Network
Exposures Product Safety
RVL Pharmaceuticals plc (NASDAQ: RVLP) to Attend H.C. Wainwright 25th Annual Global Investment Conference and Discuss UPNEEQ(R) for Treating Acquired Blepharoptosis
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Why RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference
Via Investor Brand Network
Exposures Product Safety
RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Spotlighted in New Cantor Fitzgerald Research Brief
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Enters into Agreements for $5M Registered Direct Offering
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Announces Q2 2023 Results, Strategic Business Review Update
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Announces Q2 2023 Results, Strategic Business Review Update
Via Investor Brand Network
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.